XSHG
600587
Market cap1.18bUSD
Oct 09, Last price
13.12CNY
1D
1.00%
1Q
9.15%
Jan 2017
-47.75%
IPO
153.28%
Name
Shinva Medical Instrument Co Ltd
Chart & performance
P/E
15.12
P/S
0.82
EPS
0.87
Div yield, %
3.85%
Shrs. gr., 5y
2.89%
Rev. gr., 5y
1.25%
Revenues
9.74b
-2.84%
Net income
526m
-23.90%
CFO
701m
+55.44%
Dividend
Jul 01, 20260.1 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 1943 and headquartered in Zibo, China, Shinva Medical Instrument Co., Ltd. is a prominent provider of medical instruments and equipment within the People's Republic of China. The company's extensive product portfolio spans a wide array of specialized areas. These include comprehensive solutions for central sterile supply departments (CSSD), pharmaceutical manufacturing, radiotherapy, and digital operating rooms. They also cater to dental practices, medical environmental protection, and experimental animal care. Furthermore, their range encompasses in vitro diagnostic reagents and instruments, as well as biomedical materials and supplies. Beyond these, Shinva also manufactures pharmaceutical machinery and air purification systems.
Key people
Caixiang Li
Finance Director · since 1999
Yue Xiang Ji
Deputy General Manager, Secretary of the Board, Director · since 2001
Zhao Xu Yang
Deputy General Manager, Director · since 2008
Yongsheng Miao
Director · since 2011
Shang Feng Xu
General Manager, Chief Engineer, Director · since 2001
Yi Xin Zhao
Chairman of the Board · since 2001
Fanxin Meng
Independent Director
Independent Director · since 2009
Headquarters & legal address
淄博高新技术产业开发区新华医疗科技园
淄博市, SD 100000
CN
淄博市, SD 100000
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||